{
  "id": 17014475,
  "title": "SK Bioscience joins US-backed project to develop Bundibugyo Ebola vaccine",
  "url": "https://urgent.news/2026/10/29/sk-bioscience-joins-us-backed-project-to-develop-bundibugyo-ebola",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-29T05:42:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times",
    "url": "https://www.koreatimes.co.kr/business/companies/20261029/sk-bioscience-joins-us-backed-project-to-develop-bundibugyo-ebola-vaccine"
  },
  "original_language": "en",
  "account": null,
  "summary": "SK Bioscience will join global partners in a U.S. government-funded project to develop and produce a vaccine against the Bundibugyo virus, a strain of Ebola spreading in the Democratic Republic of the Congo, the Korean vaccine maker said Thursday. The project, carried out with the International AIDS Vaccine Initiative (IAVI), a global nonprofit biomedical research organization, and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Ajel English",
        "title": "WHO launches clinical trial for Bundibugyo Ebola vaccines in Congo",
        "url": "https://urgent.news/2026/10/27/who-launches-clinical-trial-for-bundibugyo-ebola-vaccines-in-congo",
        "published": "2026-10-27T12:35:14.000Z"
      },
      {
        "outlet": "Fortune",
        "title": "‘Every life saved is worth celebrating’: Congo suffers over 10,000 cases of the fastest-growing and farthest-reaching Ebola outbreak in history",
        "url": "https://urgent.news/2026/10/28/every-life-saved-is-worth-celebrating-congo-suffers-over-10-000-cases",
        "published": "2026-10-28T15:50:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}